Overview
Dapeng Liu practices practicing medicine in Xi'an, China.
Their clinical expertise encompasses Triple-Negative Breast Cancer, Lung Adenocarcinoma, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
They are actively involved in clinical research, co-authoring 20 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Dapeng H. Liu
Is Dapeng H. Liu a top-rated expert for Triple-Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dapeng H. Liu is classified as an Experienced expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Dapeng H. Liu participate in research or clinical trials?
Yes. Dapeng H. Liu has published 20 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Dapeng H. Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerLiu isExperienced. Learn about Breast Cancer.
- Lung AdenocarcinomaLiu isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerLiu isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Triple-Negative Breast Cancer